Literature DB >> 19400725

Neurocognitive mechanisms in depression: implications for treatment.

Luke Clark1, Samuel R Chamberlain, Barbara J Sahakian.   

Abstract

Mood disorders collectively account for a substantial proportion of disease burden across the globe and have a devastating impact on quality of life and occupational function. Here we evaluate recent progress in understanding the neurocognitive mechanisms involved in the manifestation of mood disorders. We focus on four domains of cognitive function that are altered in patients with depression: executive control, memory, affective processing, and feedback sensitivity. These alterations implicate a distributed neural circuit composed of multiple sectors of the prefrontal cortex in interaction with subcortical regions (striatum, thalamus) and temporal lobe structures (amygdala, hippocampus). Affective processing and feedback sensitivity are highly sensitive to serotonergic manipulation and are targeted by antidepressant treatments. By drawing together cognitive, neuroanatomical, and pharmacological tiers of research, we identify treatment targets and directions for future investigation to identify people at risk, minimize relapse, and maximize long-term beneficial outcomes for those suffering from depression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19400725     DOI: 10.1146/annurev.neuro.31.060407.125618

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  129 in total

1.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

Review 2.  The emotion paradox in the aging brain.

Authors:  Mara Mather
Journal:  Ann N Y Acad Sci       Date:  2012-03-12       Impact factor: 5.691

3.  Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor.

Authors:  Xiaojun Wu; Hung Hsuchou; Abba J Kastin; Yi He; Reas S Khan; Kirsten P Stone; Michael S Cash; Weihong Pan
Journal:  Psychoneuroendocrinology       Date:  2010-08-17       Impact factor: 4.905

Review 4.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

5.  Impaired Cognitive Flexibility and Working Memory Precedes Depression: A Rat Model to Study Depression.

Authors:  Margarita M Maramis; Marlina S Mahajudin; Junaidi Khotib
Journal:  Neuropsychobiology       Date:  2020-07-24       Impact factor: 2.328

6.  Comparison of two different analysis approaches for DTI free-water corrected and uncorrected maps in the study of white matter microstructural integrity in individuals with depression.

Authors:  Maurizio Bergamino; Rayus Kuplicki; Teresa A Victor; Yoon-Hee Cha; Martin P Paulus
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

7.  Depression severity is associated with impaired facial emotion processing in a large international sample.

Authors:  Lauren A Rutter; Eliza Passell; Luke Scheuer; Laura Germine
Journal:  J Affect Disord       Date:  2020-07-10       Impact factor: 4.839

8.  The role of HIV infection, cognition, and depression in risky decision-making.

Authors:  April D Thames; Vanessa Streiff; Sapna M Patel; Stella E Panos; Steven A Castellon; Charles H Hinkin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

9.  Influence of depressive symptoms on speech perception in adverse listening conditions.

Authors:  Bharath Chandrasekaran; Kristin Van Engen; Zilong Xie; Christopher G Beevers; W Todd Maddox
Journal:  Cogn Emot       Date:  2014-08-04

10.  Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression.

Authors:  Matthew R Hilimire; Helen S Mayberg; Paul E Holtzheimer; James M Broadway; Nathan A Parks; Jordan E DeVylder; Paul M Corballis
Journal:  Brain Stimul       Date:  2014-11-24       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.